Zdrowie i gospodarka · 24/07/2020
FDA Proposes Annual Summary Reporting Requirements Under the Right to Try Act
The FDA is proposing rules to implement the Right to Try Act of 2017, requiring sponsors and manufacturers of investigational drugs to submit annual summaries of their use by eligible patients.
Source: Federal Register — Food and Drug AdministrationOpen original release →